Abridge is an ambient AI platform for healthcare that securely captures patient-clinician conversations and automatically generates structured, clinically accurate, and billable documentation directly within EHR systems like Epic. The company serves large U.S. health systems — including Mayo Clinic, Duke Health, and Johns Hopkins Medicine — across physician, nursing, and revenue cycle workflows, supporting 50+ specialties and 28+ languages.
- Chasing Trillion-Dollar Companies, Founder Ambition, Token Budgets, and Regulatory Capture with Sarah & Elad
- 141. Freda的投资札记第2集：Tokenmaxxing、把电机塞进蒸汽机、接力赛变篮球赛、孤独、人的连接
- Prompts Are Dead. Skills Are the New Moat.
- Baseten CEO Tuhin Srivastava on the AI Inference Crunch, Custom Models, and Building the Inference Cloud
- Voice AI Investment Surges as Enterprise Applications Gain Traction
“the majority of enterprise token consumption is going to come not from customized models, but from customized systems.”
Source→“Abridge... started as a consumer product for patients to record doctor's appointments. The company moved to selling to physicians.”
“USV was early to Twitter, Coinbase, Stripe, MongoDB, Twilio, Etsy, Duolingo and Abridge.”
“The Bridge's first product targeted consumers recording their own doctor visits; it turned out the doctor wanted to record.”
Source→“Shiv could build the team that took this like kernel of an idea that was directionally right and kind of wrong in the details to start and navigate it.”
Source→“Abridge... among the fastest-growing vertical AI companies.”
Source→“There are a lot of investors who have intellectually recognized this idea of AI companies delivering services value. They don't act like they believe it. They look at everything a little bit more linearly, right? So think of if you're looking at Harvey or Abridge or something, then they think about a per seat or per lawyer or per doctor TAM.”
Source→“Abridge has been working on this problem for close to 10 years now. And it's given them a massive advantage... you can't just walk in the door and say, hey, we're going to do healthcare now... That ends up being a form of a moat.”
Source→“Abridge has been working on this problem for close to 10 years now. And it's given them a massive advantage... you can't just walk in the door and say, hey, we're going to do healthcare now... That ends up being a form of a moat.”
Source→“Healthcare — whether Abridge or Open Evidence — has around $200 million.”
Source→“Harvey ($8B), Abridge, Decagon ($1.5B), Glean ($7.2B at $100M ARR)... The switching cost lives in the workflow integration and the data corpus.”
Source→“There are doctors right now who we've heard who won't sign up to join a healthcare system, a hospital, if they don't have Abridge. It's one of those moments where all of a sudden, almost overnight, over the course of like three to four years, something just became table stakes.”
Source→“Led Abridge's seed and Series A. Shiv identified them as the right partner not through traditional channels but by studying their public intellectual patterns”
Source→“NVIDIA is an investor in Abridge. Jensen Huang personally engages with portfolio companies, including late-night calls, with extremely fast response SLAs.”
Source→“Henry Kravis — Co-founder of KKR, investor in Abridge. Provided a pivotal reframe on the IPO question.”
Source→“Abridge was founded in 2018 but only became 'hot' around 2023 — a five-year wilderness walk.”
Source→“People, I think, in 2023 thought that was like last mile. That's actually most of it is that part. The model piece is much less.”
Source→“Rather than competing head-on with Microsoft (which acquired Nuance for $20B+), Abridge built from the conversation signal up into revenue cycle.”
Source→“Abridge cited as the exemplar of application-layer defensibility through workflow depth and proprietary clinical data. 'They've basically got this very, very deep integration into hospitals, into clinician workflows...'”
Source→“HonorHealth deployed Abridge to 500 physicians and, within two months, had a waiting list of 150 more doctors requesting access.”
Source→“Identified as CEO of Abridge in the context of the HonorHealth deployment”
Source→“Norquist acknowledged that a small but significant chunk of practitioners in his health system are concerned around data privacy when it comes to AI recording doctor-patient calls, and if it could be a liability to malpractice suits.”
Source→“After an appointment, Abridge uses its proprietary models to generate a full medical note that's ready to drop into the patient's electronic health records, along with queues on follow-ups, test orders, or prescriptions.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.